Matthew Wiley
2023
In 2023, Matthew Wiley earned a total compensation of $1.3M as SVP and Chief Commercial Officer at BioXcel Therapeutics, a 34% decrease compared to previous year.
Compensation breakdown
| Option Awards | $560,556 |
|---|---|
| Salary | $445,200 |
| Stock Awards | $250,388 |
| Other | $8,250 |
| Total | $1,264,394 |
Wiley received $560.6K in option awards, accounting for 44% of the total pay in 2023.
Wiley also received $445.2K in salary, $250.4K in stock awards and $8.3K in other compensation.
Rankings
In 2023, Matthew Wiley's compensation ranked 922nd out of 2,647 executives tracked by ExecPay. In other words, Wiley earned more than 65.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 922 out of 2,647 | 65th |
Division Manufacturing | 548 out of 1,447 | 62nd |
Major group Chemicals And Allied Products | 378 out of 817 | 54th |
Industry group Drugs | 367 out of 783 | 53rd |
Industry Pharmaceutical Preparations | 246 out of 555 | 56th |
Source: SEC filing on April 29, 2024.
Wiley's colleagues
We found two more compensation records of executives who worked with Matthew Wiley at BioXcel Therapeutics in 2023.